Gene Edited & Engineered Stem Cell-Oncolytic Virus Platform Drives Immunotherapy for Metastatic Cancers
Time: 3:45 pm
day: Day Two
Details:
- Gene editing and engineering techniques have been combined with stem cell and oncolytic virus technology to develop a powerful platform for immunotherapy in metastatic cancers
- The platform utilizes gene editing tools, such as CRISPR-Cas9, to modify stem cells and oncolytic viruses with specific anti-cancer properties
- Stem cells, with their ability to self-renew and differentiate into various cell types, act as delivery vehicles for the oncolytic viruses
